TREACE MED CONCEPTS INC shareholders Q2 2023

TREACE MED CONCEPTS INC's ticker is TMCI and the CUSIP is 89455T109. A total of 138 filers reported holding TREACE MED CONCEPTS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

TREACE MED CONCEPTS INC shareholders Q2 2023
NameSharesValueWeighting ↓
AMALGAMATED BANK 6,394$1640.00%
Zurcher Kantonalbank (Zurich Cantonalbank) 6,785$173,5600.00%
Bank of New York Mellon Corp 163,299$4,177,1880.00%
VOYA INVESTMENT MANAGEMENT LLC 17,985$460,0560.00%
Mirae Asset Global Investments Co., Ltd. 20,725$530,1460.00%
Rockefeller Capital Management L.P. 11,599$204,3840.00%
DIMENSIONAL FUND ADVISORS LP 75,469$1,930,4970.00%
PRICE T ROWE ASSOCIATES INC /MD/ 9,157$2350.00%
Invesco Ltd. 16,484$421,6610.00%
OSAIC HOLDINGS, INC. 729$18,6430.00%
PRINCIPAL FINANCIAL GROUP INC 13,535$346,2260.00%
Covestor Ltd 6$00.00%
BANK OF AMERICA CORP /DE/ 59,151$1,513,0820.00%
Hillsdale Investment Management Inc. 130$3,3250.00%
JANUS HENDERSON GROUP PLC 19,796$506,1860.00%
BARCLAYS PLC 19,274$4750.00%
JANE STREET GROUP, LLC 37,435$957,5870.00%
Legal & General Group Plc 36,173$925,3040.00%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 18,477$472,6420.00%
Citadel Advisors 26,000$665,0800.00%
External links

This page lists TREACE MED CONCEPTS INC's shareholders in Q2 2023. To view TREACE MED CONCEPTS INC's shareholder history, click here.